We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

RiboMed Launches Improved Prognostic Multi Biomarker Epigenetic Test for Brain Cancer

News   Apr 12, 2012

 
RiboMed Launches Improved Prognostic Multi Biomarker Epigenetic Test for Brain Cancer
 
 
 

RELATED ARTICLES

Blood Test Could Predict Onset of Tuberculosis

News

Scientists at UCL have shown a blood test could predict the onset of tuberculosis three to six months before people become unwell, a finding which could help better target antibiotics and save countless lives.

READ MORE

Targeting “DNA Rewiring” To Reduce Breast Cancer Relapse

News

Epigenetic changes occur in the DNA of breast cancer cells that have developed a resistance to hormone therapy, an effective treatment for ER+ breast cancer, which accounts for 70% of all diagnoses.

READ MORE

Researchers Develop First Diagnostic Test for Novel Coronavirus in China

News

Researchers from the DZIF have developed a new laboratory assay to detect the novel Chinese coronavirus. The assay protocol has now been published by WHO as a guideline for diagnostic detection.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Diagnostics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE